Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients

BACKGROUND: In randomized trials (SHARP [Study of Heart and Renal Protection], IMPROVE‐IT [Improved Reduction of Outcomes: Vytorin Efficacy International Trial]), combination of statin and ezetimibe resulted in additional reduction of cardiovascular events. The reduction was greater in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Osman, Littmann, Karin, Gustafsson, Ulf, Pramfalk, Camilla, Öörni, Katariina, Larsson, Lilian, Minniti, Mirko E., Sahlin, Staffan, Camejo, German, Parini, Paolo, Eriksson, Mats
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405603/
https://www.ncbi.nlm.nih.gov/pubmed/30561264
http://dx.doi.org/10.1161/JAHA.118.009876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405603/
https://www.ncbi.nlm.nih.gov/pubmed/30561264
http://dx.doi.org/10.1161/JAHA.118.009876

Ejemplares similares